145 related articles for article (PubMed ID: 34674955)
1. Cardiac Implantable Electronic Devices: Reoperations and the Competing Risk of Death.
Gillam MH; Pratt NL; Inacio MCS; Shakib S; Caughey GE; Sanders P; Lau DH; Roughead EE
Heart Lung Circ; 2022 Apr; 31(4):537-543. PubMed ID: 34674955
[TBL] [Abstract][Full Text] [Related]
2. Estimate and reporting of longevity for cardiac implantable electronic devices: a proposal for standardized criteria.
Censi F; Calcagnini G; Mattei E; Ricci RP; Zoni Berisso M; Landolina M; Boriani G
Expert Rev Med Devices; 2021 Dec; 18(12):1203-1208. PubMed ID: 34854774
[TBL] [Abstract][Full Text] [Related]
3. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
[TBL] [Abstract][Full Text] [Related]
4. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
6. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
[TBL] [Abstract][Full Text] [Related]
7. "Real life" longevity of implantable cardioverter-defibrillator devices.
Manolis AS; Maounis T; Koulouris S; Vassilikos V
Clin Cardiol; 2017 Sep; 40(9):759-764. PubMed ID: 28543134
[TBL] [Abstract][Full Text] [Related]
8. Reduced incidence of CIED infections with peri- and post-operative antibiotic use in CRT-P/D and ICD procedures.
Senaratne JM; Wijesundera J; Chhetri U; Beaudette D; Sander A; Hanninen M; Gulamhusein S; Senaratne M
Medicine (Baltimore); 2022 Oct; 101(40):e30944. PubMed ID: 36221436
[TBL] [Abstract][Full Text] [Related]
9. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
[TBL] [Abstract][Full Text] [Related]
10. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.
Kirkfeldt RE; Johansen JB; Nohr EA; Jørgensen OD; Nielsen JC
Eur Heart J; 2014 May; 35(18):1186-94. PubMed ID: 24347317
[TBL] [Abstract][Full Text] [Related]
11. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
[TBL] [Abstract][Full Text] [Related]
12. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
[TBL] [Abstract][Full Text] [Related]
13. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry.
Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
Scand Cardiovasc J; 2020 Aug; 54(4):239-247. PubMed ID: 32054352
[No Abstract] [Full Text] [Related]
14. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).
Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Johansen JB
Eur Heart J; 2019 Jun; 40(23):1862-1869. PubMed ID: 31155647
[TBL] [Abstract][Full Text] [Related]
15. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
16. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator.
Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440
[TBL] [Abstract][Full Text] [Related]
18. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
[TBL] [Abstract][Full Text] [Related]
19. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
20. Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.
Doppalapudi H; Barrios J; Cuellar J; Gannon M; Yamada T; Kumar V; Maddox WR; Plumb VJ; Brown TM; McElderry HT
J Cardiovasc Electrophysiol; 2017 May; 28(5):552-558. PubMed ID: 28181727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
